Soumettre la recherche
Mettre en ligne
Drug development and regulation
•
Télécharger en tant que PPT, PDF
•
1 j'aime
•
820 vues
R
raj kumar
Suivre
Signaler
Partager
Signaler
Partager
1 sur 45
Télécharger maintenant
Recommandé
Drug development and regulation
Drug development and regulation
raj kumar
Nda
Nda
amitgajjar85
Non-clinical drug development
Non clinical drug development
Non clinical drug development
Abhimanyu Awasthi
B. Pharm. Final Year, Sem:- VII, INDUSTRIAL PHARMACY-II, Unit 3 chapter 4 Regulatory requirements for drug approval, As per PCI Syllabus
Regulatory requirements for drug approval
Regulatory requirements for drug approval
Audumbar Mali
Anda
Anda
Malla Reddy College of Pharmacy
Globalization Of Clinical Trials 2010 Josep M. Badenas
Globalization Of Clinical Trials 2010 Josep M. Badenas
josepmariabadenas
Dug development and regulation
Dug development and regulation
Umair hanif
m, pharm pharmaceutical technology, non-clinical drug development
Non-clinical drug development
Non-clinical drug development
JayeshRajput7
Recommandé
Drug development and regulation
Drug development and regulation
raj kumar
Nda
Nda
amitgajjar85
Non-clinical drug development
Non clinical drug development
Non clinical drug development
Abhimanyu Awasthi
B. Pharm. Final Year, Sem:- VII, INDUSTRIAL PHARMACY-II, Unit 3 chapter 4 Regulatory requirements for drug approval, As per PCI Syllabus
Regulatory requirements for drug approval
Regulatory requirements for drug approval
Audumbar Mali
Anda
Anda
Malla Reddy College of Pharmacy
Globalization Of Clinical Trials 2010 Josep M. Badenas
Globalization Of Clinical Trials 2010 Josep M. Badenas
josepmariabadenas
Dug development and regulation
Dug development and regulation
Umair hanif
m, pharm pharmaceutical technology, non-clinical drug development
Non-clinical drug development
Non-clinical drug development
JayeshRajput7
Nda ipr
Nda ipr
Malla Reddy College of Pharmacy
FDA’s Drug Review Process
FDA’s drug review process
FDA’s drug review process
Anthony Melvin Crasto Ph.D
Sameeta Malik, Abira Khalid, Iffrah Naushad Qaisara Boota
Lecture # 03 New Drug Approval and Development Process.
Lecture # 03 New Drug Approval and Development Process.
PakistanPharmaCareerDoor
USFDA Approval Process For Drug Products & Biological Product i.e NDA Vs. BLA Comparison of NDA and BLA application process in USA. IND, NDA, ANDA & BLA dossier submission procedure.
USFDA NDA Vs BLA
USFDA NDA Vs BLA
Girish Swami
PHARMACOLOGY
Drug approval process
Drug approval process
Prathyusha Rani
Regulatory requirements for drug approval - industrial pharmacy IIDrug Development Teams, Non-Clinical Drug Development, Pharmacology, Drug Metabolism and Toxicology, General considerations of Investigational New Drug (IND) Application, Investigator’s Brochure (IB) and New Drug Application (NDA), Clinical research / BE studies, Clinical Research Protocols, Biostatistics in Pharmaceutical Product Development, Data Presentation for FDA Submissions, Management of Clinical Studies.
Regulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy II
Jafarali Masi
Introduction Brief description of the drug and the therapeutic class to which it belongs Chemical and pharmaceutical information Animal Pharmacolog Animal Toxicology Human/Clinical Pharmacology phase I Therapeutic exploratory trials (Phase II) Therapeutic confirmatory trials (Phase III) Special Studies Geriatrics, pediatrics, pregnant or nursing women Regulatory status in other countries Prescribing information Samples and Testing Protocol/s
NEW DRUG APPLICATION (NDA)
NEW DRUG APPLICATION (NDA)
GOKULAKRISHNAN S
Investigational medical product dossier is document made to apply for clinical trial application in European Union. European Medical Agency is regulatory body for drug approval in European Union.
Investigational medical product dossier
Investigational medical product dossier
SachinFartade
CBER: One of six main centers of FDA
Center for Biologics Evaluation and Research
Center for Biologics Evaluation and Research
RajeswariS12
overview regulatory of USA ,Europe
Overview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,india
shabana parveen
Basics in Drug Approval Process with reference to Orange book
Orange book
Orange book
Rucha Pathak
The NDA application is the vehicle through which drug sponsors, such as biotech and pharmaceutical companies, formally propose that the FDA approve a new pharmaceutical for sale and marketing
New Drug Application [NDA]
New Drug Application [NDA]
Sagar Savale
Details about Food and Drugs Administration (FDA) Read More - http://www.pharmaguideline.com/2015/12/top-5-tips-for-fda-inspection.html
What is FDA?
What is FDA?
Pharmaguideline
ABBREVIATED NEW DRUG APPLICATION (ANDA)
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
Anthony Melvin Crasto Ph.D
Excellent overview of the Investigational New Drug (IND) and New Drug Application (NDA) Process by Susan Honig, MD.
The Investigational New Drug (IND) and New Drug Application (NDA) Process
The Investigational New Drug (IND) and New Drug Application (NDA) Process
Carrie O'Connor
quality assuarance
Quality assuarance
Quality assuarance
JayeshRajput7
Non-clinical contract research organizations (CROs) have become an integral part of drug discovery and development to support sponsors research needs, expedite timelines and provide an extension of technical and scientific support.
Non clinical drug development
Non clinical drug development
Rama Shukla
Describing the Industry's/sponsor's/drug manufacturers' perspective of the Investigational New Drug Application (IND) program based on the survey conducted by the Office Of Inspector General (OIG).
IND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspective
AYESHA NAZEER
Unit-II,Unit-II, Chapter 2. Regulatory Authorities and Agencies. B. Pharm. Final Year, Sem-VIII, BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory). As PCI Syllabus.
2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.
Audumbar Mali
Regulatory framework for new drug development and GCP, GMP, CPCSEA guidelines
Regulatory framework for new drug development
Regulatory framework for new drug development
Dr. Mohit Kulmi
Cns stimulants
Cns stimulants
raj kumar
Hypo & hyperthyriodism
Hypo & hyperthyriodism
raj kumar
Contenu connexe
Tendances
Nda ipr
Nda ipr
Malla Reddy College of Pharmacy
FDA’s Drug Review Process
FDA’s drug review process
FDA’s drug review process
Anthony Melvin Crasto Ph.D
Sameeta Malik, Abira Khalid, Iffrah Naushad Qaisara Boota
Lecture # 03 New Drug Approval and Development Process.
Lecture # 03 New Drug Approval and Development Process.
PakistanPharmaCareerDoor
USFDA Approval Process For Drug Products & Biological Product i.e NDA Vs. BLA Comparison of NDA and BLA application process in USA. IND, NDA, ANDA & BLA dossier submission procedure.
USFDA NDA Vs BLA
USFDA NDA Vs BLA
Girish Swami
PHARMACOLOGY
Drug approval process
Drug approval process
Prathyusha Rani
Regulatory requirements for drug approval - industrial pharmacy IIDrug Development Teams, Non-Clinical Drug Development, Pharmacology, Drug Metabolism and Toxicology, General considerations of Investigational New Drug (IND) Application, Investigator’s Brochure (IB) and New Drug Application (NDA), Clinical research / BE studies, Clinical Research Protocols, Biostatistics in Pharmaceutical Product Development, Data Presentation for FDA Submissions, Management of Clinical Studies.
Regulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy II
Jafarali Masi
Introduction Brief description of the drug and the therapeutic class to which it belongs Chemical and pharmaceutical information Animal Pharmacolog Animal Toxicology Human/Clinical Pharmacology phase I Therapeutic exploratory trials (Phase II) Therapeutic confirmatory trials (Phase III) Special Studies Geriatrics, pediatrics, pregnant or nursing women Regulatory status in other countries Prescribing information Samples and Testing Protocol/s
NEW DRUG APPLICATION (NDA)
NEW DRUG APPLICATION (NDA)
GOKULAKRISHNAN S
Investigational medical product dossier is document made to apply for clinical trial application in European Union. European Medical Agency is regulatory body for drug approval in European Union.
Investigational medical product dossier
Investigational medical product dossier
SachinFartade
CBER: One of six main centers of FDA
Center for Biologics Evaluation and Research
Center for Biologics Evaluation and Research
RajeswariS12
overview regulatory of USA ,Europe
Overview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,india
shabana parveen
Basics in Drug Approval Process with reference to Orange book
Orange book
Orange book
Rucha Pathak
The NDA application is the vehicle through which drug sponsors, such as biotech and pharmaceutical companies, formally propose that the FDA approve a new pharmaceutical for sale and marketing
New Drug Application [NDA]
New Drug Application [NDA]
Sagar Savale
Details about Food and Drugs Administration (FDA) Read More - http://www.pharmaguideline.com/2015/12/top-5-tips-for-fda-inspection.html
What is FDA?
What is FDA?
Pharmaguideline
ABBREVIATED NEW DRUG APPLICATION (ANDA)
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
Anthony Melvin Crasto Ph.D
Excellent overview of the Investigational New Drug (IND) and New Drug Application (NDA) Process by Susan Honig, MD.
The Investigational New Drug (IND) and New Drug Application (NDA) Process
The Investigational New Drug (IND) and New Drug Application (NDA) Process
Carrie O'Connor
quality assuarance
Quality assuarance
Quality assuarance
JayeshRajput7
Non-clinical contract research organizations (CROs) have become an integral part of drug discovery and development to support sponsors research needs, expedite timelines and provide an extension of technical and scientific support.
Non clinical drug development
Non clinical drug development
Rama Shukla
Describing the Industry's/sponsor's/drug manufacturers' perspective of the Investigational New Drug Application (IND) program based on the survey conducted by the Office Of Inspector General (OIG).
IND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspective
AYESHA NAZEER
Unit-II,Unit-II, Chapter 2. Regulatory Authorities and Agencies. B. Pharm. Final Year, Sem-VIII, BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory). As PCI Syllabus.
2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.
Audumbar Mali
Regulatory framework for new drug development and GCP, GMP, CPCSEA guidelines
Regulatory framework for new drug development
Regulatory framework for new drug development
Dr. Mohit Kulmi
Tendances
(20)
Nda ipr
Nda ipr
FDA’s drug review process
FDA’s drug review process
Lecture # 03 New Drug Approval and Development Process.
Lecture # 03 New Drug Approval and Development Process.
USFDA NDA Vs BLA
USFDA NDA Vs BLA
Drug approval process
Drug approval process
Regulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy II
NEW DRUG APPLICATION (NDA)
NEW DRUG APPLICATION (NDA)
Investigational medical product dossier
Investigational medical product dossier
Center for Biologics Evaluation and Research
Center for Biologics Evaluation and Research
Overview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,india
Orange book
Orange book
New Drug Application [NDA]
New Drug Application [NDA]
What is FDA?
What is FDA?
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
The Investigational New Drug (IND) and New Drug Application (NDA) Process
The Investigational New Drug (IND) and New Drug Application (NDA) Process
Quality assuarance
Quality assuarance
Non clinical drug development
Non clinical drug development
IND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspective
2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.
Regulatory framework for new drug development
Regulatory framework for new drug development
En vedette
Cns stimulants
Cns stimulants
raj kumar
Hypo & hyperthyriodism
Hypo & hyperthyriodism
raj kumar
Bronchodilators
Bronchodilators
raj kumar
Antifungal agents
Antifungal agents
raj kumar
Cancer chemotherapy
Cancer chemotherapy
raj kumar
Antipsychotics
Antipsychotics
raj kumar
Local anesthetics
Local anesthetics
raj kumar
Ihd
Ihd
raj kumar
Cns depressants
Cns depressants
raj kumar
Drugs and the kidney
Drugs and the kidney
raj kumar
Pulmonary pathology copd
Pulmonary pathology copd
raj kumar
Acid peptic disease nsaids
Acid peptic disease nsaids
raj kumar
Drug development
Drug development
raj kumar
Antiarrhythmicdrugs
Antiarrhythmicdrugs
raj kumar
Antilipemics
Antilipemics
raj kumar
Antidysrhythmics
Antidysrhythmics
raj kumar
Antimicrobe drugs -grossly
Antimicrobe drugs -grossly
raj kumar
Pain & analgesia
Pain & analgesia
raj kumar
Initiation &management of drug therapy
Initiation &management of drug therapy
raj kumar
Endocrine disruptor
Endocrine disruptor
raj kumar
En vedette
(20)
Cns stimulants
Cns stimulants
Hypo & hyperthyriodism
Hypo & hyperthyriodism
Bronchodilators
Bronchodilators
Antifungal agents
Antifungal agents
Cancer chemotherapy
Cancer chemotherapy
Antipsychotics
Antipsychotics
Local anesthetics
Local anesthetics
Ihd
Ihd
Cns depressants
Cns depressants
Drugs and the kidney
Drugs and the kidney
Pulmonary pathology copd
Pulmonary pathology copd
Acid peptic disease nsaids
Acid peptic disease nsaids
Drug development
Drug development
Antiarrhythmicdrugs
Antiarrhythmicdrugs
Antilipemics
Antilipemics
Antidysrhythmics
Antidysrhythmics
Antimicrobe drugs -grossly
Antimicrobe drugs -grossly
Pain & analgesia
Pain & analgesia
Initiation &management of drug therapy
Initiation &management of drug therapy
Endocrine disruptor
Endocrine disruptor
Similaire à Drug development and regulation
1. INTRODUCTION 2. DEFINITIONS 3. FDA, CFR 4. IND 5. NDA 6. ANDA 7. Conclusion & 8.REFERENCES
Drug development process and regulatory submissions
Drug development process and regulatory submissions
Suyog
INDA- Investigation New Drug Application, useful presentation for UG and PG students
INDA- Investigation New Drug Application
INDA- Investigation New Drug Application
Dr. Jigar Vyas
INDA definition Types of IND Format Review Process
INVESTIGATIONAL NEW DRUG APPLICATION
INVESTIGATIONAL NEW DRUG APPLICATION
Komal Yadav
Usfda sana 1
Usfda sana 1
sanjay patil
ANDA APPLICATION
ANDA FDA APPLICATION
ANDA FDA APPLICATION
Roshan Bodhe
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and nda
swati2084
USFDA
USFDA
USFDA
vivek vyas
Naresh... anda ppt
Naresh... anda ppt
Malla Reddy College of Pharmacy
This SlideShare gives an overview on how a drug is discovered, researched, developed, tested and reviewed for approval. It follows the current standard of approval set by the Food and Drug Administration (FDA), a federal agency of the United States Department of Health and Human Services. The process is generally divided into 4 Stages: Pre-Clinical, Clinical, New Drug Application (NDA) Review & Post-Marketing.
Clinical Trials & Drug Approval Process
Clinical Trials & Drug Approval Process
Kumaraguru Veerasamy
Comprehensive and detailed about Investigational Drug
Investaigational drugs
Investaigational drugs
Sultan Alharbi
No research without action,no action without research.
PART 1 _ Documentation of drug trials and regulatory filings (1).pptx
PART 1 _ Documentation of drug trials and regulatory filings (1).pptx
DilsarGohil1
Organizational structure and application forms
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agencies
ChintamBaladattaSai
Unit-II,Chapter 1. Regulatory Approval Process B. Pharm. Final Year, Sem-VIII, BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory).
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
Audumbar Mali
A regulatory strategy is critical to the commercialization of biomedical technologies. In particular, technologies such as new drugs and medical devices have more regulatory needs, and the strategy should be considered simultaneous to a commercialization pathway.
The Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory Environment
Jonathan Servoss
ANDAHatch-Waxman Act: Global Impact, Issues and Challenges
Anda 2011 ppt raaj gprac
Anda 2011 ppt raaj gprac
Raaj Global Pharma Regulatory Affiairs
5. Unit-V- Regulatory Concepts. B. Pharm. Final Year, Sem-VIII, BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory), As PCI Syllabus.
5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.
Audumbar Mali
Introduction to Investigational new drug application, New drug application, Abbrevated new drug application
INDA/NDA/ANDA
INDA/NDA/ANDA
Rohit Bhosale
Pharmacotherapeutics
RegulatoryIssues In Drug management cycle
RegulatoryIssues In Drug management cycle
HarunMohamed7
An overview on drug discovery and development process
Drug discovery and development
Drug discovery and development
Sujith Thokala
contains all the information starting from history to the format of biologics.
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of Biologics
Arpitha Aarushi
Similaire à Drug development and regulation
(20)
Drug development process and regulatory submissions
Drug development process and regulatory submissions
INDA- Investigation New Drug Application
INDA- Investigation New Drug Application
INVESTIGATIONAL NEW DRUG APPLICATION
INVESTIGATIONAL NEW DRUG APPLICATION
Usfda sana 1
Usfda sana 1
ANDA FDA APPLICATION
ANDA FDA APPLICATION
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and nda
USFDA
USFDA
Naresh... anda ppt
Naresh... anda ppt
Clinical Trials & Drug Approval Process
Clinical Trials & Drug Approval Process
Investaigational drugs
Investaigational drugs
PART 1 _ Documentation of drug trials and regulatory filings (1).pptx
PART 1 _ Documentation of drug trials and regulatory filings (1).pptx
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agencies
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
The Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory Environment
Anda 2011 ppt raaj gprac
Anda 2011 ppt raaj gprac
5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.
INDA/NDA/ANDA
INDA/NDA/ANDA
RegulatoryIssues In Drug management cycle
RegulatoryIssues In Drug management cycle
Drug discovery and development
Drug discovery and development
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of Biologics
Plus de raj kumar
The umbilical cord
The umbilical cord
raj kumar
The placenta
The placenta
raj kumar
The foetal membranes
The foetal membranes
raj kumar
Physiology of reproduction
Physiology of reproduction
raj kumar
Minor complaints during pregnancy
Minor complaints during pregnancy
raj kumar
Diagnosis of pregnancy
Diagnosis of pregnancy
raj kumar
Antenatal care
Antenatal care
raj kumar
Postpartum mood disorders
Postpartum mood disorders
raj kumar
Normal and abnormal puerperium
Normal and abnormal puerperium
raj kumar
Version
Version
raj kumar
Vacuum extraction (ventouse)
Vacuum extraction (ventouse)
raj kumar
Symphysiotomy
Symphysiotomy
raj kumar
Forceps delivery
Forceps delivery
raj kumar
Episiotomy
Episiotomy
raj kumar
Caesarean section
Caesarean section
raj kumar
Normal labour
Normal labour
raj kumar
Anatomy of the foetal skull
Anatomy of the foetal skull
raj kumar
Anatomy of the female pelvis
Anatomy of the female pelvis
raj kumar
Active management of normal labour
Active management of normal labour
raj kumar
Thyrotoxicosis in pregnancy
Thyrotoxicosis in pregnancy
raj kumar
Plus de raj kumar
(20)
The umbilical cord
The umbilical cord
The placenta
The placenta
The foetal membranes
The foetal membranes
Physiology of reproduction
Physiology of reproduction
Minor complaints during pregnancy
Minor complaints during pregnancy
Diagnosis of pregnancy
Diagnosis of pregnancy
Antenatal care
Antenatal care
Postpartum mood disorders
Postpartum mood disorders
Normal and abnormal puerperium
Normal and abnormal puerperium
Version
Version
Vacuum extraction (ventouse)
Vacuum extraction (ventouse)
Symphysiotomy
Symphysiotomy
Forceps delivery
Forceps delivery
Episiotomy
Episiotomy
Caesarean section
Caesarean section
Normal labour
Normal labour
Anatomy of the foetal skull
Anatomy of the foetal skull
Anatomy of the female pelvis
Anatomy of the female pelvis
Active management of normal labour
Active management of normal labour
Thyrotoxicosis in pregnancy
Thyrotoxicosis in pregnancy
Drug development and regulation
1.
DRUG DEVELOPMENT AND
REGULATION www.freelivedoctor.com
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
www.freelivedoctor.com
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
Télécharger maintenant